Cytokinetics (CYTK) had the highest return between December 13, 2023 and December 28, 2023 by a mid-cap US stock, returning 137.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 12/13/2023 - 12/28/2023 | 137.08% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 12/13/2023 - 12/28/2023 | 120.33% |
Terawulf (WULF) | 12/13/2023 - 12/28/2023 | 106.85% |
Cipher Mining (CIFR) | 12/13/2023 - 12/28/2023 | 103.81% |
Hut 8 Corp Common Stock (HUT) | 12/13/2023 - 12/28/2023 | 92.94% |
Liquidia Technologies (LQDA) | 12/13/2023 - 12/28/2023 | 67.17% |
Compania de Minas Buenaventura SAA ADR (BVN) | 12/13/2023 - 12/28/2023 | 66.27% |
IREN (IREN) | 12/13/2023 - 12/28/2023 | 65.83% |
Sunrun (RUN) | 12/13/2023 - 12/28/2023 | 64% |
Arcutis Biotherapeutics (ARQT) | 12/13/2023 - 12/28/2023 | 60.98% |
Century Aluminum (CENX) | 12/13/2023 - 12/28/2023 | 59.37% |
Sezzle Inc Common Stock (SEZL) | 12/13/2023 - 12/28/2023 | 57.1% |
Xometry (XMTR) | 12/13/2023 - 12/28/2023 | 56.39% |
GeneDx (WGS) | 12/13/2023 - 12/28/2023 | 53.33% |
CleanSpark (CLSK) | 12/13/2023 - 12/28/2023 | 49.32% |
ACADIA Pharmaceuticals (ACAD) | 12/13/2023 - 12/28/2023 | 45.98% |
Triumph (TGI) | 12/13/2023 - 12/28/2023 | 44.87% |
Compass (COMP) | 12/13/2023 - 12/28/2023 | 44.57% |
Alcoa (AA) | 12/13/2023 - 12/28/2023 | 43.72% |
Recursion Pharmaceuticals (RXRX) | 12/13/2023 - 12/28/2023 | 42.99% |
CommScope (COMM) | 12/13/2023 - 12/28/2023 | 41.06% |
Apogee Therapeutics, Inc Common Stock (APGE) | 12/13/2023 - 12/28/2023 | 40.74% |
Enphase Energy (ENPH) | 12/13/2023 - 12/28/2023 | 40.7% |
Immunitybio (IBRX) | 12/13/2023 - 12/28/2023 | 40.05% |
BigBearai (BBAI) | 12/13/2023 - 12/28/2023 | 37.06% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
